1 week Where Will CRISPR Therapeutics Be in 3 Years?The Motley Fool
CRISPR Therapeutics (NASDAQ: CRSP) made a name for itself by pioneering advanced gene therapies made with technologies that didn’t exist a generation ago. Now, its challenge is to build on its prior successes to become a biotech powerhouse and prove to…
Biotech · Nasdaq 100 · Tech
X